Mission Bio

San Francisco, CA · Founded 2011 · Privately Held (backing)

Developer of a precision genomics platform designed to provide single-cell targeted DNA sequencing at single-base resolution. Mission Bio is based in San Francisco, CA and was founded in 2011. It was valued at $300 million at its later-stage round in May 2022, the last priced event on record. It has raised $212 million across 2 recorded rounds; the latest was a $28.4 million early-stage round in Jun 2018.

PMV mark · valuation
$300.0M
Oct 2026
Priced at
its later-stage round
May 2022
Total raised
$212.1M
Last round
Early Stage VC
Jun 2018

Who backs Mission Bio?

41 investors
InvestorType
Alumni VenturesVenture capital
StartX (US)Other
Keiretsu ForumOther
Evolution VC PartnersVenture capital
Sand Hill AngelsVenture capital
Novo HoldingsOther
Mayfield FundVenture capital
Chestnut Street VenturesVenture capital
Foothill VenturesVenture capital
Fusion FundVenture capital
+ 31 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Mission Bio investors

41 investors are on record for Mission Bio, including Alumni Ventures, StartX (US), Keiretsu Forum and Evolution VC Partners. By type, the record holds 12 venture capital firms and 2 growth equity firms. The early-stage round in Jun 2018 drew 32 investors.

Free account
More of Mission Bio with a free account
  • ·The complete investor list: 41 names
  • ·Watch Mission Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 41 firms already write checks for companies like Mission Bio. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View